Effect of oral anticoagulants in atrial fibrillation patients with polypharmacy: a meta-analysis
L Guo, GYH Lip - Authorea Preprints, 2023 - techrxiv.org
Aims: The aim of the present meta-analysis was to evaluate the effectiveness and safety of
non–vitamin K antagonist oral anticoagulants (NOACs) vs. vitamin K antagonists (VKAs) in …
non–vitamin K antagonist oral anticoagulants (NOACs) vs. vitamin K antagonists (VKAs) in …
[PDF][PDF] Use of Rivaroxaban in Obese Patient With Pulmonary Thromboembolism.
R Ciresa, E Ciavaglia, A Fiore, F Stefani, M Cominacini… - 2022 - scholar.archive.org
Background. There are few clinical data about e cacy and safety of Direct Oral
Anticoagulants (DOACs) for venous thromboembolism (VTE) in obese patients, especially …
Anticoagulants (DOACs) for venous thromboembolism (VTE) in obese patients, especially …